AzTrials
AzTrials

HypertensionNCT05411029

Study of Disrupted Sleep in Somali Americans

An observational study of Hypertension and Sleep Disorder, run by Mayo Clinic at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aims of this study are to determine the types and severity of previously undiagnosed sleep deficiencies in otherwise healthy Somali Americans, apply a research framework to define psychosocial, behavioral, environmental, and biological mechanisms mediating sleep deficiencies in Somali Americans, and examine the… Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Hypertension, Sleep Disorder, Healthy
What is being tested?
24 hour blood pressure (BP) monitoring and Polysomnography
Type of treatment
Pill or oral medicine
How many people
240 participants
Where
1 siteUnited States
Study dates
15 Nov 2022to Oct 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The research team will partner with Somali operated community-based health clinics, faith-based establishments, community organizations, charter schools and other educational/community centers. In addition, the research team will partner with the Somali Health Advisory Committee (SHAC), a community advisory board based in Rochester and Minneapolis/St. Paul and the Somali Community Resettlement Agency (SCRS) and Somali American Social Services Association (SASSA), two community organizations aimed at integrating Somali immigrants to the United States.

Who may be able to join

  • Subjects diagnosed with no known history of hypertension, diabetes, or sleep disorders.
  • Self-identify as Somali.
  • Adult males and females who are older than 18 years of age.

Who cannot join

  • Anyone under 18 years or over 70 years.
  • Positive pregnancy.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Somers CPL Lab contact

507-422-3499

CPLSOMALI@mayo.edu

United States1 site, 1 recruiting
  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905

    Virend Somers, MD

    Recruiting

Other trials in United States

About this study

Official title: Disrupted Sleep in Somali Americans - Implications for Hypertension Risk

The aims of this study are to determine the types and severity of previously undiagnosed sleep deficiencies in otherwise healthy Somali Americans, apply a research framework to define psychosocial, behavioral, environmental, and biological mechanisms mediating sleep deficiencies in Somali Americans, and examine the relationship between sleep deficiencies and increased blood pressure in Somali Americans.

Being tested
24 hour blood pressure (BP) monitoring, Polysomnography
Medical subject headings
Hypertension, Sleep Wake Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 24 hour blood pressure (BP) monitoringDiagnostic test

    24-hour ambulatory BP measuring device and blood pressures will be measured every 20 minutes to half hour

  • PolysomnographyDiagnostic test

    Also called Sleep Study

    Measurements will include electroencephalogram, electromyogram, electrooculogram, electrocardiogram, breathing patterns of chest and abdomen, nasal and oral airflow and oxygen saturation. Sleep stages and apneas will be scored in accordance with validated American Academy of Sleep Medicine standards.

Study groups in NCT05411029
Study groupRoleWhat they receive
Healthy Somali AmericansSomali Americans with no known history of hypertension, diabetes, or sleep disorders will have a 24 hour blood pressure monitoring and polysomnography.
Receives: Diagnostic Test: 24 hour blood pressure (BP) monitoring; Diagnostic Test: Polysomnography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Undiagnosed sleep deficiency-short sleep

    Number of subjects to have short sleep (<6 hours) as measured by the sleep study

    Measured: 1 night sleep study, approximately 8-9 hours

  2. Undiagnosed sleep deficiency-insomnia

    Number of subjects to have insomnia as measured by the sleep study

    Measured: 1 night sleep study, approximately 8-9 hours

  3. Undiagnosed sleep deficiency-obstructive sleep apnea (OSA)

    Number of subjects to have OSA as measured by the sleep study

    Measured: 1 night sleep study, approximately 8-9 hours

  4. Disrupted sleep

    Number of subjects to have disrupted sleep as measured by the sleep study

    Measured: 1 night sleep study, approximately 8-9 hours

  5. Blood pressure (BP) during wakefulness

    Average BP as measured by 24 hour BP monitoring, reported in mmHg

    Measured: Day 2

  6. Blood pressure (BP) during sleep

    Average BP as measured by 24 hour BP monitoring, reported in mmHg

    Measured: Day 2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jun 2022
  2. Study start15 Nov 2022
  3. Primary completionOct 2028 (estimated)
  4. Study completionOct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Prospective
Enrolment
240 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05411029
Sponsor's protocol ID
22-004192
Other IDs
R01HL160619
Status last verified
Sep 2026
First submitted
6 Jun 2022
Last updated
14 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Greenlund IM, Bock JM, Govindan N, Kantas D, Singh P, Covassin N, Somers VK. Blood Pressure and Heart Rate Response to Orthostasis in Somali Americans. J Racial Ethn Health Disparities. 2026 Jun;13(3):1961-1966. doi: 10.1007/s40615-025-02389-7. Epub 2025 Mar 15.

    PubMed 40088388
  • Greenlund I, Bock J, Govindan N, Kantas D, Singh P, Covassin N, Somers V. Blood Pressure and Heart Rate Response to Orthostasis in Somali Americans. Res Sq [Preprint]. 2024 Oct 21:rs.3.rs-4925722. doi: 10.21203/rs.3.rs-4925722/v1.

    PubMed 39502777

Questions about this trial

What is this clinical trial studying?

An observational study of Hypertension and Sleep Disorder, run by Mayo Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 14 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Somers CPL Lab (507-422-3499, CPLSOMALI@mayo.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Undiagnosed sleep deficiency-short sleep (time frame: 1 night sleep study, approximately 8-9 hours). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05411029, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in